To further understand better of PARPi response in prostate cancer, in this study, we performed a genome-wide CRISPR screen in prostate cancer cells with 3D culture condition and identified TBL1XR1 as a factor regulating sensitivity to PARPi in prostate cancer cells. Here, TBL1XR1 is linked to prostate carcinoma.